Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays

Vaccine

Volumn 29, Issue 18, 2011, Pages 3377-3389

  Lorbetskie, Barry ^a   Wang, Jun ^a   Gravel, Caroline ^a   Allen, Cynthia ^a   Walsh, Mike ^a   Rinfret, Aline ^a   Li, Xuguang ^a   Girard, Michel ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Hemagglutinin; Influenza; Pandemic H1N1; Quantification; Reversed phase HPLC; Single radial immunodiffusion; Universal antibody; Vaccine

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ACCURACY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNODIFFUSION; INFLUENZA VIRUS A H1N1; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING;

BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS;

EID: 79954891276     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.090     Document Type: Article

References (18)

1. Garcia-Cañas V., Lorbetskie B., Girard M. Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columns. J Chromatogr A 2006, 1123:225-232.
2. Bucher D.J., Li S.S.-L., Kehoe J.M., Kilbourne E.D. Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences. Proc Natl Acad Sci U S A 1976, 73:238-242.
3. Phelan M.A., Cohen K.A. Gradient optimization principles in reversed-phase high performance liquid chromatography and the separation of Influenza virus components. J Chromatogr 1983, 266:55-66.
4. Calam D.H., Davidson J. Isolation of Influenza viral proteins by size-exclusion and ion-exchange high performance liquid chromatography: the influence of conditions on separation. J Chromatogr 1984, 296:285-292.
5. Garcia-Canas V., Lorbetskie B., Bertrand D., Cyr T.D., Girard M. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem 2007, 79:3164-3172.
6. Garcia-Cañas V., Lorbetskie B., Cyr T.D., Hefford M.A., Smith S., Girard M. Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry. Biologicals 2010, 38:294-302.
7. Kapteyn J.C., Saidi M.D., Dijkstra R., Kars C., Tjon J., Weverling G.J., et al. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells: a novel RP-HPLC method. Vaccine 2006, 14:3137-3144.
8. Kapteyn J.C., Porre A.M., de Rond E.J.P., Hessels W.B., Tijms M.A., Kessen H., et al. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine 2009, 27:1468-1477.
9. Cyr T.D., Bertrand D., Girard M., Garcia-Canas V., Lorbetskie B. The application of proteomics methodology to influenza vaccine formulations. Proceedings of the 55th ASMS Conference on Mass Spectrometry 2007, log No. 1931.
10. Williams T.L., Luna L., Guo Z., Cox N.J., Pirkle J.L., Donis R.O., et al. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008, 26:2510-2520.
11. Chun S., Li C., Van Domselaar G., Wang J., Farnsworth A., Cui X., et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008, 26:6068-6076.
12. Wood J.M., Schild G.C., Newman R.W., Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand 1977, 5:237-247.
13. Pace C.N., Vajdos F., Fee L., Grimsley G., Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995, 11:2411-2423.
14. Wood J.M., Mumford J.A., Dunleavy U., Seagroatt V., Newman R.W., Thornton D., et al. Single radial immunodiffusion potency tests for inactivated equine influenza vaccines. Equine infectious diseases V 1988, The University Press of Kentucky, pp. 74-9.
15. Carstensen B, Gurrin LC. MethComp: functions for analysis of method comparison studies. R package version 0.6.0/r5. 2009. http://r-forge.r-project.org/projects/methcomp/.
16. R Development Core Team R: a language and environment for statistical computing 2009, R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org.
17. Carstensen B., Simpson J., Gurrin L.C. Statistical models for assessing agreement in method comparison studies with replicate measurements. Int J Biostat 2008, 4(1). Article 16.
18. SAS/STAT software, Version 9 of the SAS System for Windows. Copyright © 2006 SAS Institute Inc., Cary, NC, USA.